Loading memory…
Loading memory…
Patent portfolio assigned to JelikaLite Corp (verified via public assignee records). Estimated patent count: 2. Pediatric neuro-health company; Cognilum transcranial photobiomodulation (tPBM) wearable for autism (FDA breakthrough device designation). Head-wearable light-therapy patents (US20240325779A1, WO2021076756A1) assigned to JelikaLite LLC. No named customers (pre-commercial/clinical).